US Stock MarketDetailed Quotes

IBO Impact BioMedical

Watchlist
  • 1.250
  • -0.300-19.35%
Close Oct 14 16:00 ET
  • 1.280
  • +0.030+2.41%
Post 20:01 ET
14.37MMarket Cap-3387P/E (TTM)

Impact BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
9.14%-666K
29.78%-712K
-27.16%-2.85M
-19.28%-433K
16.33%-671K
-34.74%-733K
-90.24%-1.01M
0.00%-2.24M
63.88%-363K
-62.77%-802K
Net income from continuing operations
21.25%-882K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
49.79%-1.18M
-40.18%-1.12M
-13.81%-849K
0.00%-7.26M
37.11%-3.37M
-154.68%-2.34M
Depreciation and amortization
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
0.36%280K
0.72%280K
0.72%280K
0.00%1.11M
0.00%278K
0.17%279K
Deferred tax
----
----
--0
--0
----
----
----
0.00%-621K
-378.12%-1.88M
----
Change In working capital
-158.88%-63K
101.35%6K
3.56%436K
8.73%548K
4,420.00%226K
565.22%107K
-584.62%-445K
0.00%421K
39.23%504K
-96.65%5K
-Change in receivables
----
----
---128K
----
----
----
----
--0
----
----
-Change in prepaid assets
-129.41%-40K
97.47%-2K
273.33%104K
328.57%96K
-288.46%-49K
2,042.86%136K
-113.51%-79K
0.00%-60K
-320.00%-42K
866,766.67%26K
-Change in payables and accrued expense
-135.38%-23K
102.19%8K
-4.37%460K
6.23%580K
412.07%181K
209.52%65K
-1,207.14%-366K
0.00%481K
66.46%546K
-160.47%-58K
Cash from discontinued investing activities
Operating cash flow
9.14%-666K
29.78%-712K
-27.16%-2.85M
-19.28%-433K
16.33%-671K
-34.74%-733K
-90.24%-1.01M
0.00%-2.24M
63.88%-363K
-62.77%-802K
Investing cash flow
Cash flow from continuing investing activities
109.09%1K
0
95.70%-15K
100.36%1K
0.00%-1K
-134.38%-11K
96.19%-4K
0.00%-349K
-103.37%-275K
99.96%-1K
Net PPE purchase and sale
--0
--0
93.48%-18K
--0
---1K
---12K
---5K
0.00%-276K
---276K
--0
Net investment purchase and sale
----
----
--0
--0
----
----
----
0.00%-65K
--0
--0
Net other investing changes
----
----
137.50%3K
0.00%1K
--0
-98.82%1K
101.08%1K
0.00%-8K
-99.98%1K
99.93%-1K
Cash from discontinued investing activities
Investing cash flow
109.09%1K
--0
95.70%-15K
100.36%1K
0.00%-1K
-134.38%-11K
96.19%-4K
0.00%-349K
-103.37%-275K
99.96%-1K
Financing cash flow
Cash flow from continuing financing activities
-10.86%665K
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
-73.36%773K
Net issuance payments of debt
-10.86%665K
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
-73.36%773K
Cash from discontinued financing activities
Financing cash flow
-10.86%665K
-29.89%713K
12.49%2.87M
-56.96%232K
12.55%870K
22.30%746K
62.72%1.02M
0.00%2.55M
107.46%539K
-73.36%773K
Net cash flow
Beginning cash position
100.00%2K
-50.00%1K
-95.65%2K
99.01%201K
-97.71%3K
-96.97%1K
-95.65%2K
0.00%46K
8.60%101K
78.72%131K
Current changes in cash
--0
200.00%1K
97.73%-1K
-102.02%-200K
760.00%198K
-97.96%2K
92.31%-1K
0.00%-44K
-52.31%-99K
-249.63%-30K
End cash Position
-33.33%2K
100.00%2K
-50.00%1K
-50.00%1K
99.01%201K
-97.71%3K
-96.97%1K
0.00%2K
0.00%2K
8.60%101K
Free cash flow
10.60%-666K
30.13%-712K
-13.94%-2.87M
32.24%-433K
16.21%-672K
-36.95%-745K
-91.18%-1.02M
0.00%-2.52M
50.12%-639K
-62.77%-802K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 9.14%-666K29.78%-712K-27.16%-2.85M-19.28%-433K16.33%-671K-34.74%-733K-90.24%-1.01M0.00%-2.24M63.88%-363K-62.77%-802K
Net income from continuing operations 21.25%-882K-17.55%-998K39.26%-4.41M62.54%-1.26M49.79%-1.18M-40.18%-1.12M-13.81%-849K0.00%-7.26M37.11%-3.37M-154.68%-2.34M
Depreciation and amortization -0.36%279K0.00%280K0.63%1.12M0.72%280K0.36%280K0.72%280K0.72%280K0.00%1.11M0.00%278K0.17%279K
Deferred tax ----------0--0------------0.00%-621K-378.12%-1.88M----
Change In working capital -158.88%-63K101.35%6K3.56%436K8.73%548K4,420.00%226K565.22%107K-584.62%-445K0.00%421K39.23%504K-96.65%5K
-Change in receivables -----------128K------------------0--------
-Change in prepaid assets -129.41%-40K97.47%-2K273.33%104K328.57%96K-288.46%-49K2,042.86%136K-113.51%-79K0.00%-60K-320.00%-42K866,766.67%26K
-Change in payables and accrued expense -135.38%-23K102.19%8K-4.37%460K6.23%580K412.07%181K209.52%65K-1,207.14%-366K0.00%481K66.46%546K-160.47%-58K
Cash from discontinued investing activities
Operating cash flow 9.14%-666K29.78%-712K-27.16%-2.85M-19.28%-433K16.33%-671K-34.74%-733K-90.24%-1.01M0.00%-2.24M63.88%-363K-62.77%-802K
Investing cash flow
Cash flow from continuing investing activities 109.09%1K095.70%-15K100.36%1K0.00%-1K-134.38%-11K96.19%-4K0.00%-349K-103.37%-275K99.96%-1K
Net PPE purchase and sale --0--093.48%-18K--0---1K---12K---5K0.00%-276K---276K--0
Net investment purchase and sale ----------0--0------------0.00%-65K--0--0
Net other investing changes --------137.50%3K0.00%1K--0-98.82%1K101.08%1K0.00%-8K-99.98%1K99.93%-1K
Cash from discontinued investing activities
Investing cash flow 109.09%1K--095.70%-15K100.36%1K0.00%-1K-134.38%-11K96.19%-4K0.00%-349K-103.37%-275K99.96%-1K
Financing cash flow
Cash flow from continuing financing activities -10.86%665K-29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K-73.36%773K
Net issuance payments of debt -10.86%665K-29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K-73.36%773K
Cash from discontinued financing activities
Financing cash flow -10.86%665K-29.89%713K12.49%2.87M-56.96%232K12.55%870K22.30%746K62.72%1.02M0.00%2.55M107.46%539K-73.36%773K
Net cash flow
Beginning cash position 100.00%2K-50.00%1K-95.65%2K99.01%201K-97.71%3K-96.97%1K-95.65%2K0.00%46K8.60%101K78.72%131K
Current changes in cash --0200.00%1K97.73%-1K-102.02%-200K760.00%198K-97.96%2K92.31%-1K0.00%-44K-52.31%-99K-249.63%-30K
End cash Position -33.33%2K100.00%2K-50.00%1K-50.00%1K99.01%201K-97.71%3K-96.97%1K0.00%2K0.00%2K8.60%101K
Free cash flow 10.60%-666K30.13%-712K-13.94%-2.87M32.24%-433K16.21%-672K-36.95%-745K-91.18%-1.02M0.00%-2.52M50.12%-639K-62.77%-802K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday+0.82%